ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Abstract Number: 722

Increased Blood Pressure Visit-to-Visit Variability in Patients with Systemic Lupus Erythematosus: Association with Inflammation, Comorbidities and Increased Mortality

Tyler Reese1, Alyson Dickson1, Jacquelyn E. Neal2, Jocelyn S. Gandelman3, Omair A. Khan2, April Barnado4, William Dupont2, C. Michael Stein1 and Cecilia P. Chung1, 1Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, 2Department of Biostatistics, Vanderbilt University Medical Center, Nashville, TN, 3Vanderbilt University School of Medicine, Nashville, TN, 4Division of Rheumatology and Immunology, Vanderbilt University Medical Center, Nashville, TN

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: Cardiovascular disease, hypertension, Lupus, renal disease and systemic lupus erythematosus (SLE)

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, October 21, 2018

Session Title: Systemic Lupus Erythematosus – Clinical Poster I: Clinical Manifestations and Comorbidity

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Patients with systemic lupus erythematosus (SLE) have increased mortality compared to the general population. As outcomes related to disease control have improved, this mortality difference has been explained increasingly by higher rates of cardiovascular and renal disease. Blood pressure visit-to-visit variability (BPV) has emerged as a risk factor for cardiovascular and renal outcomes in the general population but little is known about this relationship in SLE. We hypothesized that SLE patients have greater BPV than control subjects and that BPV is associated with higher comorbidity burden and increased mortality in SLE.

Methods: We identified a cohort of patients with SLE using a previously validated algorithm (PPV 94%) from a de-identified version of an academic medical center’s electronic health record (EHR) and then frequency-matched (age, race, and sex) SLE patients to a control group in a ~5:1 control-case ratio. We excluded patients with fewer than three visits or age <18 years at the time of the first relevant ICD9 code (710.0 for SLE, any code for controls). We extracted demographic variables (age, race, and sex), ICD9 codes, laboratory results, and outpatient blood pressure values from the EHR. We compared BPV in SLE patients and controls. The primary outcome was systolic blood pressure coefficient of variation. Secondary outcomes included standard deviation, average real variation, and successive variation for both systolic and diastolic blood pressure. Second, we examined the association between BPV with clinical characteristics and mortality in patients with SLE.

Results: 899 patients with SLE and 4172 controls met inclusion criteria. Age, sex, and race were similar among the SLE and control groups. Patients with SLE had higher systolic BPV 9.7% [7.8-11.8] than the control group 9.2% [7.4-11.2], p<0.001 measured by coefficient of variation. All other measures of BPV were significantly higher in patients with SLE than in controls. In SLE patients, BPV correlated significantly with age, creatinine, C-reactive protein, and the Charlson comorbidity score; but not with C3, C4, and body mass index (Table). There was no statistically significant difference in BPV by sex, but Caucasian SLE patients [9.6% (7.9-11.4)] had lower BPV than SLE patients who were African-American [10.3% (7.9-12.9)] or patients from other races [10.4% (7.6-12.3)], p=0.015. Over a median follow-up of 6.5 years, 91 patients died. After adjustment for age, sex, race, and baseline Charlson comorbidity score, higher BPV was associated with death in patients with SLE [OR=1.24, 95% CI 1.16-1.33, p<0.001].

Conclusion: SLE patients had a higher BPV than the control group. In patients with SLE, higher BPV was associated with older age, higher creatinine, inflammation, comorbidity index, and mortality.


Disclosure: T. Reese, None; A. Dickson, None; J. E. Neal, None; J. S. Gandelman, None; O. A. Khan, None; A. Barnado, None; W. Dupont, None; C. M. Stein, None; C. P. Chung, None.

To cite this abstract in AMA style:

Reese T, Dickson A, Neal JE, Gandelman JS, Khan OA, Barnado A, Dupont W, Stein CM, Chung CP. Increased Blood Pressure Visit-to-Visit Variability in Patients with Systemic Lupus Erythematosus: Association with Inflammation, Comorbidities and Increased Mortality [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/increased-blood-pressure-visit-to-visit-variability-in-patients-with-systemic-lupus-erythematosus-association-with-inflammation-comorbidities-and-increased-mortality/. Accessed January 27, 2023.
  • Tweet
  • Email
  • Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/increased-blood-pressure-visit-to-visit-variability-in-patients-with-systemic-lupus-erythematosus-association-with-inflammation-comorbidities-and-increased-mortality/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2023 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences